Clinical Trial

Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial

Study acronym: OZONE-HERNIA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study looks at whether a special wound dressing containing ozonated oil can reduce early wound inflammation after open inguinal hernia surgery. Open inguinal hernia repair is a common operation, and although infection rates are low, many patients experience redness, swelling, tenderness, or discomfort at the surgical site during the first days after surgery. Participants undergoing elective open inguinal hernia repair will be randomly assigned to receive either an ozonated oil-impregnated dressing or a standard sterile dressing after the operation. The main outcome is the level of wound inflammation measured on the third day after surgery. Other outcomes include wound temperature, pain levels, cosmetic healing, and wound-related problems during the first 30 days. The ozonated oil used in this study is a CE-certified medical product that is already used in routine wound care. This pilot study aims to provide preliminary data to help determine whether ozonated oil dressing may improve early wound healing compared with standard care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-27.
Status change: Not Yet Recruiting → Recruiting 2026-02-10
Trial Details
NCT Number NCT07328698
Lead Sponsor Nigde Omer Halisdemir University
Conditions Inguinal Hernia Unilateral, Postoperative Wound Inflammation
Enrollment 60 participants
Start Date 2026-02-10
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-11